Ameta-analysis of high-dose versus low-dose 4-factor prothrombin complex concentrate for reversal of factor Xa inhibitor-associated intracerebral hemorrhage

被引：0
|
作者：
Coleman, C. [1 ]
Karadenes, A. [1 ]
Cassano, C. [1 ]
Baker, W. L. [1 ]
机构：
[1] Univ Connecticut, Storrs, CT USA
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Discussion of "Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa"
    Van Dusen, Rachel
    AMERICAN JOURNAL OF SURGERY, 2018, 215 (05): : 780 - 781
  • [42] Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
    Tao, Jing
    Bukanova, Elena N.
    Akhtar, Shamsuddin
    JOURNAL OF INTENSIVE CARE, 2018, 6
  • [43] The Effect of 4-Factor Prothrombin Complex Concentrate to Reverse Factor Xa Inhibitors in Patients With Traumatic Intracranial Hemorrhage
    Rauh, Jessica L.
    Torosian, Taron
    Thompson, Anothony
    Evangelista, Meagan
    Hoth, Jason
    AMERICAN SURGEON, 2024, : 1904 - 1906
  • [44] Activated Prothrombin Complex Concentrate Versus 4-Factor Prothrombin Complex Concentrate for Vitamin K-Antagonist Reversal
    Rowe, A. Shaun
    Dietrich, Scott K.
    Phillips, John W.
    Foster, Kaci E.
    Canter, Joshua R.
    CRITICAL CARE MEDICINE, 2018, 46 (06) : 943 - 948
  • [45] Modelling the effects of 4-factor prothrombin complex concentrate for the management of factor Xa-associated bleeding
    Muir, Ineke
    Herzog, Eva
    Brechmann, Markus
    Ghobrial, Oliver
    Rezvani Sharif, Alireza
    Hoffman, Maureane
    PLOS ONE, 2024, 19 (09):
  • [46] Four-factor prothrombin complex concentrate plus andexanet alfa for reversal of factor Xa inhibitor-associated bleeding: Case series
    Liu, JiTong
    Elsamadisi, Pansy
    Philips, Eli
    Bauer, Kenneth A.
    Eche, Ifeoma M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (16) : 1323 - 1329
  • [47] Low-dose 4-factor PCC for urgent warfarin reversal
    Zemrak, W.
    Smith, K.
    Rolfe, S.
    Hayes, T.
    Trowbridge, R.
    Seder, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 885 - 885
  • [48] Retrospective review of Andexanet Alfa versus 4-Factor Prothrombin Complex Concentrate for reversal of DOAC-Associated Intracranial Hemorrhage
    Troyer, Camille
    Nguyen, Wesley
    Xie, Annie
    Wimer, Dexter
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 55 (01) : 149 - 155
  • [49] Retrospective review of Andexanet Alfa versus 4-Factor Prothrombin Complex Concentrate for reversal of DOAC-Associated Intracranial Hemorrhage
    Camille Troyer
    Wesley Nguyen
    Annie Xie
    Dexter Wimer
    Journal of Thrombosis and Thrombolysis, 2023, 55 : 149 - 155
  • [50] Economic Evaluation of Andexanet Versus Prothrombin Complex Concentrate for Reversal of Factor Xa-Associated Intracranial Hemorrhage
    Micieli, Andrew
    Demchuk, Andrew M.
    Wijeysundera, Harindra C.
    STROKE, 2021, 52 (04) : 1390 - 1397
12345